Ethical considerations in clinical pharmacogenomics research
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (7) , 247-249
- https://doi.org/10.1016/s0165-6147(00)01493-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatmentTrends in Pharmacological Sciences, 1999
- Genetic markers to predict polygenic disease: a new problem for social genetics.QJM: An International Journal of Medicine, 1999
- BRCA1 and BRCA2 gene mutations and risk of breast cancer:American Journal of Preventive Medicine, 1999
- Selecting subjects for participation in clinical research: one sphere of justice.Journal of Medical Ethics, 1999
- Protecting Communities in Research: Philosophical and Pragmatic ChallengesCambridge Quarterly of Healthcare Ethics, 1999
- How will knowledge of the human genome affect drug therapy?British Journal of Clinical Pharmacology, 1999
- Getting the right drug into the right patientNature Biotechnology, 1997
- Genetic Discrimination: Perspectives of ConsumersScience, 1996
- The introduction of newborn screening for phenylketonuriaEuropean Journal of Pediatrics, 1996
- The Use of Genetic Information in Large-scale Clinical Trials: Applications to Alzheimer ResearchAlzheimer Disease & Associated Disorders, 1996